Tamil Nadu is under the spotlight after a spate of child deaths linked to adulterated cough syrup manufactured by Sresan Pharmaceuticals. The deaths have now increased to 23, as two more children, Garvik Pawar, and Mayank Suryawanshi, both aged between one and two years, died of acute kidney failure and brain damage at GMCH, Nagpur.
The study found that syrup was contaminated with diethylene glycol (DEG), an industrial solvent used in brake fluids.
Madhya Pradesh Chief Minister Mohan Yadav has pointed out that the DMK-run Tamil Nadu government is placing questions of Sresan’s licence renewal despite the hazards. He reminded the manufacturer of their obligation to the very end and then assured the families that they would receive financial help.
Tamil Nadu Health Minister Ma Subramanian stated that the Centre and MP government had given the go-ahead but that TN officials had informed them without delay. Subramanian Prakash declared the termination of the Sresan cough syrup factory and released the two senior drug inspector officers who resigned due to the negligence of supervision.
Also Read: WHO asks India for Clarification on Coldrif Syrup Exports
The officials took away 589 bottles in Chhindwara and more than 1,500 bottles statewide. It was ascertained that Batch SR-13 contained a high enough concentration of DEG to be hazardous, thus the company’s licence was revoked, and its Kanchipuram unit was sealed.
After thorough investigations, a seven-member MP SIT physically Ranganathan Govindan, the owner of Sresan Pharmaceuticals, along with his manager and lab assistant. They were taken to a Chennai court, which allowed them to be briefly held at Chhindwara jail by issuing transit warrants. The case keeps on making headlines all across the country, it is indicative of the loosening of drug manufacturing oversight and regulatory compliance.
